{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Irosustat",
  "nciThesaurus": {
    "casRegistry": "288628-05-7",
    "chebiId": "",
    "chemicalFormula": "C14H15NO5S",
    "definition": "Steroid sulfatase inhibitor BN 83495 selectively binds to and inhibits steroid sulfatase (STS), which may inhibit the production of locally active estrogens and so inhibit estrogen-dependent cell growth in tumor cells, such as those of the breast, ovary, and endometrium. STS is a cytoplasmic enzyme responsible for the conversion of circulating inactive estrone sulfate and estradiol sulfate to biologically active unconjugated estrone and estradiol, respectively.",
    "fdaUniiCode": "366037O6O7",
    "identifier": "C79827",
    "preferredName": "Irosustat",
    "semanticType": "Pharmacologic Substance",
    "subclassOf": [
      "C1742",
      "C471"
    ],
    "synonyms": [
      "667 Coumate",
      "BN83495",
      "IROSUSTAT",
      "Irosustat",
      "STX 64",
      "Steroid Sulfatase Inhibitor BN 83495"
    ]
  }
}